AI stethoscope revolutionises heart failure diagnosis
New technology trials aim to cut costs and save lives with early heart failure detection.
The NHS’s ability to diagnose heart failure is being transformed through a new AI-powered stethoscope, developed using patient data.
Heart failure carries a higher risk of death than most cancers and is increasingly common, affecting 2 per cent of the UK population and consuming 4 per cent of the NHS budget.
Now surgeries across the country are trialling an AI-powered stethoscope that is able to, with high levels of sensitivity, quickly detect any weakening of the heart’s ability to pump.
By increasing early diagnosis, the NHS can maximise the benefits of treatments, improve symptoms, quality of life and survival.
Heart failure admission alone costs the UK more than £2 billion annually, and an unacceptable 80 per cent of these diagnoses are made during emergency admissions.
It is estimated that implementing this tool in primary care could save the NHS £2,400 per patient by eliminating the potential need for an unplanned A&E visit.
More than 3 million patients have already been involved in the trial. It's projected that nationwide implementation in primary care could lead to £100m in savings for the NHS, alongside the impact of early intervention to maximise the benefits of treatment to improve survival and quality of life for patients.
Last edited: 17 June 2025 8:57 am